US brand comparison

Mounjaro vs Zepbound

Last updated

These brands contain tirzepatide. Compare their approved uses, formulations, and self-pay prices. Products are not interchangeable.

Mounjaro vs Zepbound: the lowest prices now

Mounjaro vs Zepbound: active ingredients, formulations, and manufacturers
CompareMounjaroZepbound
Active ingredientTirzepatideGIP/GLP-1TirzepatideGIP/GLP-1
How it is taken

Injection

Once weekly

Injection

Once weekly

ManufacturerEli LillyEli Lilly
Direct evidence

What was actually compared

No direct trial comparing these exact brands is included in our reviewed catalog. Sharing an ingredient does not establish the same outcomes at different doses or formulations.

Weight-loss results by formulation

Each result belongs to its named trial and dose. Separate trials have different participants and methods; these figures are not a direct comparison.

Mounjaro vs Zepbound: sourced weight-loss results by formulation
CompareMounjaroZepbound
Injection evidence

No reviewed weight-loss result for this brand and formulation.

−20.9% (nejm.org/doi/full/10.1056/NEJMoa2206038) (-20.9% at 72 wks · SURMOUNT-1 · 15 mg weekly (Zepbound))

SURMOUNT-1 · -20.9% at 72 wks (nejm.org)

15 mg weekly (Zepbound)

Accounts for treatment discontinuation

Product-specific costs

Entry price and maintenance price

Self-pay quotes, not insurance estimates. Each figure identifies the product, provider, and dose where published.

Mounjaro vs Zepbound: published self-pay prices by formulation
CompareMounjaroZepbound
Injection prices

Advertised entry price

from $499/28 days (lilly.com/lillydirect/mounjaro)

28-day supply (lilly.com)

≈ $534.64 per 30 days at this quoted rate

Checked on lilly.com

Mounjaro single-dose pens

LillyDirect (Eli Lilly) · maker's own price

self-pay, four weekly pens; published starting rate at each dose

Price conditions

self-pay, four weekly pens; published starting rate at each dose

The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.

28-day supply

Published maintenance dose

from $499/28 days (lilly.com/lillydirect/mounjaro)

28-day supply (lilly.com)

≈ $534.64 per 30 days at this quoted rate

Checked on lilly.com

At 15 mg

Mounjaro single-dose pens

LillyDirect (Eli Lilly) · maker's own price

Published price at 15 mg

Price conditions

Published price at 15 mg

The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.

The same starting rate is published for all six strengths, 2.5-15 mg. Taxes and additional fees may apply.

28-day supply

Advertised entry price

$299-$449/28 days (zepbound.lilly.com/hcp/coverage-savings)

28-day supply (zepbound.lilly.com)

≈ $320.36 per 30 days at this quoted rate

Checked on zepbound.lilly.com

Zepbound KwikPen (multi-dose pen)

LillyDirect (Eli Lilly) · maker's own price

self-pay cash, by dose ($299 / $399 / $449)

Price conditions

self-pay cash, by dose ($299 / $399 / $449)

Each pen holds four doses, one month's (28-day) supply. $299 at 2.5 mg and $399 at 5 mg; $449 at 7.5 to 15 mg under the Self Pay Journey offer, which holds only with a refill within 45 days.

28-day supply

Published maintenance dose

$449/28 days (zepbound.lilly.com/hcp/coverage-savings)

28-day supply (zepbound.lilly.com)

≈ $481.07 per 30 days at this quoted rate

Checked on zepbound.lilly.com

At 15 mg

Zepbound KwikPen (multi-dose pen)

LillyDirect (Eli Lilly) · maker's own price

Published price at 15 mg

Price conditions

Published price at 15 mg

Each pen holds four doses, one month's (28-day) supply. $299 at 2.5 mg and $399 at 5 mg; $449 at 7.5 to 15 mg under the Self Pay Journey offer, which holds only with a refill within 45 days.

Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg).

28-day supply

How these quotes are selected

For each price basis, we prefer a recently checked manufacturer-direct quote, then a recently checked provider quote for that brand and formulation. Within each group, documented 30-day costs come first, lowest to highest. Quotes without a documented supply period have no cost rank. Older quotes appear as dated references only when no current quote is tracked. Providers may differ between entry and maintenance prices. Missing maintenance prices are never replaced with entry prices. Compounded products, combined brand quotes, and membership-only fees are excluded. Prices at different doses are not equivalent treatment costs; confirm supply length, eligibility, and added fees.

Every cash quote was checked on or after . Each quote shows its own check date. A quoted maintenance dose is not a dosing recommendation. Our methodology

From each FDA label

Mounjaro vs Zepbound side effects

Rate on the medicine, with the placebo rate in brackets, at the highest dose in each label's table. These come from separate trials, so they are not a head-to-head comparison.

Side effectMounjaro 15 mgZepbound 15 mg
Nausea18% (4%)28% (8%)
Diarrhea17% (9%)23% (8%)
Vomiting9% (2%)13% (2%)
Constipation7% (1%)11% (5%)
Abdominal pain5% (4%)10% (5%)
Indigestion5% (3%)10% (4%)
Decreased appetite11% (1%)not in table
Fatiguenot in table7% (3%)
Dizzinessnot in table4% (2%)
Injection site reactionsnot in table8% (2%)
Burpingnot in table5% (1%)
Refluxnot in table5% (2%)
Gasnot in table4% (2%)
Bloatingnot in table4% (2%)
Hair lossnot in table5% (1%)
From FDA and CMS records

Mounjaro vs Zepbound: timing, generics and coverage

Read from each FDA label, FDA's Orange Book and CMS's Part D files, and updated when they change.

BrandSoonest top doseHalf-lifeGeneric approved?Patent on the medicine toOn Medicare Part D, 2025
Mounjaro15 mg from week 21about 5 daysNoJun 14, 20391,592,517
Zepbound15 mg from week 21about 5-6 daysNoMay 13, 2036160,298

How long each takes · Generics and patents · Who covers what

US prescribing information

Approved uses by formulation

Eligibility, contraindications, and warnings are in each product's full prescribing information.

Mounjaro vs Zepbound: reviewed approved uses by formulation
CompareMounjaroZepbound
Injection

Glucose control in adults and children 10+ with type 2 diabetes; cardiovascular risk reduction in adults with type 2 diabetes at high cardiovascular risk.

US prescribing information (pi.lilly.com) (Mounjaro Injection prescribing information)

Reviewed Nov 4, 2026

Weight management in adults with obesity, or overweight with a weight-related condition; moderate to severe obstructive sleep apnea in adults with obesity.

US prescribing information (pi.lilly.com) (Zepbound Injection prescribing information)

Reviewed Nov 4, 2026

Full evidence and safety information

Updated automatically

What changed for Mounjaro and Zepbound

Written from each source's own record as it changes. Every change on GLPcompare

Questions

Mounjaro vs Zepbound: common questions

Is Mounjaro the same as Zepbound?

They contain the same medicine, tirzepatide, but they are separate products with their own FDA labels, approved uses and doses, and they are not interchangeable. Mounjaro: Type 2 diabetes (age 10+); cardiovascular risk reduction. Zepbound: Chronic weight management; obstructive sleep apnea in obesity.

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.